Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...

The best defense against prompt injection and other AI attacks is to do some basic engineering, test more, and not rely on AI to protect you. If you want to know what is actually happening in ...

Prompt injection vulnerabilities may never be fully mitigated as a category and network defenders should instead focus on ways to reduce their impact, government security experts have warned. Then ...

The UK’s National Cyber Security Centre (NCSC) has highlighted a potentially dangerous misunderstanding surrounding emergent prompt injection attacks against generative artificial intelligence (GenAI) ...

With the official release of Microsoft's latest database offering, let's see what was improved and what still needs some work. Today, at Ignite, Microsoft announced the general availability of SQL ...

SAP has released its November security updates that address multiple security vulnerabilities, including a maximum severity flaw in the non-GUI variant of the SQL Anywhere Monitor and a critical code ...

Lethal injection is tainted with error, ineptitude and secrecy that's led to many botched executions and unnecessary suffering. Missouri passed a law shielding the identity of the people involved in ...

Texas, which historically drives the number of executions nationwide, is approaching a grim milestone of 600 people put to death by lethal injection since the early 1980s. But for the past 10 years, a ...

Mounjaro is a prescription injection that can be used to help manage blood sugar levels in adults with type 2 diabetes. It can be administered as an injection under the skin in your abdomen, thigh, or ...

This report presents the findings from a comprehensive web application security assessment conducted for Inlanefreight. The assessment focused on identifying SQL injection vulnerabilities within a ...

Leqembi (lecanemab-irmb) is a prescription medicine approved to treat early stages of Alzheimer's disease, such as mild cognitive impairment or mild dementia. The recent FDA approval of Leqembi IQLIK ...